Skip to main content
logo
Supha Pharmachem Limited (BOM:539561)
India flag India · Delayed Price · Currency is INR
0.3300
+0.0100 (3.13%)
At close: Jul 31, 2026

Supha Pharmachem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
5,2694,05340,4175,0985,048900.36
Revenue Growth
-84.25%-89.97%692.75%1.00%460.66%3015.21%
Gross Profit
154.8871.12403.24159.6963.0922.85
Operating Income
56.0711.91333.9765.6517.026.62
Net Income
122.5421.29327.354.2610.784.81
Earnings Per Share
0.190.050.810.130.030.01
EPS Growth
-53.82%-93.84%503.20%404.03%124.37%73.22%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
13.1614.2715.24218.5614.368.11
Total Debt
10,87511,414577.03--105.01
Net Cash (Debt)
-10,862-11,400-561.79218.5614.36-96.91
Net Cash Growth
---1422.30%--
Net Cash Per Share
-16.74-28.27-1.390.540.04-0.24

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
-9,984-11,348-741.61205112.83-102.13
Capital Expenditures
-58.24---0.43-0.5-0.39
Free Cash Flow
-10,042-11,348-741.61204.57112.33-102.51
Free Cash Flow Growth
---82.12%--

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Gross Margin
2.94%1.75%1.00%3.13%1.25%2.54%
Operating Margin
1.06%0.29%0.83%1.29%0.34%0.73%
Pretax Margin
3.00%1.08%1.25%1.45%0.30%0.73%
Profit Margin
2.33%0.53%0.81%1.06%0.21%0.53%
FCF Margin
-190.59%-280.03%-1.84%4.01%2.23%-11.39%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
PE Ratio
1.7634.4633.4248.9446.2632.97
P/FCF Ratio
---12.984.44-
PS Ratio
0.030.180.270.520.100.18